Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".
Naoko ShigetaTomoyuki YokoseShuji MurakamiTetsuya IsakaKanako ShinadaEmi YoshiokaAtsuya NaritaKengo KatakuraTetsuro KondoTerufumi KatoTakuya NagashimaHaruhiro SaitoHiroyuki ItoPublished in: Thoracic cancer (2024)
This study shows a clear difference between AD and NFAD in terms of cancer progression, pathological features of the main tumor, genetic characteristics, and PD-L1 expression.